Open AccessOR33-6 The Neurokinin 3 Receptor Antagonist, Fezolinetant, Is Effective in Treatment of Menopausal Vasomotor Symptoms: A Randomized, Placebo-Controlled, Double-Blind, Dose-Ranging Study
Author(s) -
Graeme L. Fraser,
Samuel Lederman,
Arthur Waldbaum,
Misun Lee,
Laurence Skillern,
Steven Ramael
Publication year - 2019
Publication title -
journal of the endocrine society
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.046
H-Index - 20
ISSN - 2472-1972
DOI - 10.1210/js.2019-or33-6
Subject(s) - medicine , vasomotor , placebo , discontinuation , population , randomized controlled trial , alternative medicine , environmental health , pathology